Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Special dietary proteins

A protein and quality technology, applied in peptide/protein components, food science, drug combination, etc., can solve problems such as heavy family burden, intestinal metabolic disorder, poor patient treatment compliance, etc., achieve production cost reduction, broad market prospects, The effect of great practical application value

Active Publication Date: 2020-02-04
湖北康肽药业有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are many disadvantages in the traditional phenylalanine-restricted diet therapy: (1) Since the protein of most foods contains phenylalanine, the food that can be selected is very limited, and you can only choose protein-free or very low-protein foods. (2) Using amino acid compound powder as a substitute for dietary protein, because many amino acids have a strong bitter taste and special unpleasant smell, resulting in amino acid compound powder The taste of the food is poor, and the patient's treatment compliance is poor; in addition, due to oral administration of a large amount of free amino acids, the osmotic pressure of the intestinal tract is disturbed, causing intestinal discomfort and intestinal metabolic disorders; thirdly, the food form that amino acid powder can be made into is very limited , long-term use leads to a decline in the quality of life of patients
(3) Continuous neurological and psychological problems due to poor quality of life; (4) Long-term dietary restrictions or single choices lead to nutritional deficiencies; (5) The cost of special foods and nutrients is relatively high, and the family burden is heavy
LN AA supplements also face the disadvantages of oral amino acids, such as heavy bitter taste, poor taste, intestinal discomfort and intestinal dysfunction, etc.
[0013] Common high-quality food proteins, such as whey protein, egg protein, soybean protein, etc., have relatively high phenylalanine content (about 3.1-5.35%) [Christopher J. Rasmussen, Nutritional Supplements in Sports and Exercise, (2008); Maria Minnaar, USDA, (1994)], not suitable for consumption by patients with phenylketonuria
In addition, the ratio of LNAA to phenylalanine of these proteins is low (about 5.89-11.06), which cannot inhibit the entry of phenylalanine into the brain
At present, it is the only natural low-phenylalanine food protein suitable for patients with phenylketonuria --- glycomacropeptide. Use, affect the taste experience
[0014] At present, there is no protein that can meet all the amino acid requirements of patients with phenylketonuria and can be used as the only protein food source for patients with phenylketonuria
At the same time, there is no dietary protein that meets the low phenylalanine content and contains a high proportion of LNAA amino acids

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Special dietary proteins
  • Special dietary proteins
  • Special dietary proteins

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] Example 1. Construction of Escherichia coli strains expressing phenylalanine-free protein and protein fermentation production and preparation

[0049] This example takes the E. coli K12 expression system as an example to illustrate the strain construction, protein expression and purification of the E. coli expression system for recombinant expression of no / low phenylalanine proteins. The Escherichia coli K12 (Escherichia coli K12) used in the examples was purchased from the American Type Culture Collection (ATCC). Unless otherwise specified, the reagents used in the experiment are all commercially available scientific research reagents or consumables. The ingredients and preparation methods of various reagents and media can refer to the operation in the routine experiment manual.

[0050] 1. Construction of Escherichia coli expression strains

[0051] 1. Construction of expression vector

[0052] According to the phenylalanine-free target protein sequence (PKU1, see S...

Embodiment 2

[0064] Example 2. Construction of no / low phenylalanine protein strains expressed by Bacillus and protein fermentation production and preparation

[0065] This example takes the Bacillus licheniformis expression system as an example to illustrate the strain construction, protein expression and preparation of the Bacillus expression system expressing no / low phenylalanine protein. The Bacillus licheniformis strain (B. licheniformis CICC 10266) used in the examples was purchased from China Industrial Microorganism Culture Collection and Management Center.

[0066] The pEBKan194-GFP plasmid used in the examples is pKGFP194ts in another patent application of the applicant (application number: 201610410811.8), and its construction information can be found in Example 1 of the specification of this application.

[0067] Unless otherwise specified, the reagents used in the experiment are all commercially available scientific research reagents or consumables. The ingredients and preparat...

Embodiment 3

[0101] Example 3. Construction of yeast recombinant expression of phenylalanine-free protein strains and protein fermentation production and preparation

[0102] This example takes the Pichia pastoris expression system as an example to describe the strain construction, protein expression and purification preparation of the yeast expression system expressing no / low phenylalanine protein. The Pichia pastoris X-33 and plasmid pPICZαA used in the examples were purchased from Invitrogen. Unless otherwise specified, the reagents used are all commercially available research reagents or consumables. The ingredients and preparation methods of various reagents and media can refer to the operation in the routine experiment manual.

[0103] 1. Construction of recombinant Pichia pastoris expressing phenylalanine-free protein

[0104] 1. Construction of recombinant expression plasmid pPICZαA-PKU3

[0105] According to the phenylalanine-free target protein sequence (PKU3, see SEQ ID NO: 3 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a group of special dietary proteins, and belongs to the field of phenylketonuria dietetic therapy. The proteins are prepared by the following steps: artificially designing andoptimizing proteins with high natural expression quantity, reducing the phenylalanine content, and increasing the LNAA content at the same time. Through genetic engineering bacterium transformation and production process optimization, the obtained protein powder is high in purity and good in taste, and the content of phenylalanine in blood of a phenylketonuria model mouse can be effectively controlled when the phenylketonuria model mouse is fed with the protein powder. Therefore, the protein powder is suitable for dietary therapy of phenylketonuria. The production cost of the recombinant phenylalanine-free / low-phenylalanine protein powder prepared by the invention can be reduced to the price of a common protein product, and the protein powder has huge practical application value and wide market prospect.

Description

technical field [0001] The invention belongs to the field of diet therapy for phenylketonuria, and in particular relates to a recombinant protein with no / low phenylalanine content suitable for patients with hyperphenylalaninemia or phenylketonuria. Background technique [0002] Phenylketonuria (PKU) is a rare genetic disease of amino acid metabolism. The incidence rate in Chinese newborns is about 1:11800, and the total number of PKU patients in China is about 120,000. PKU is an autosomal recessive inheritance, which is due to the absence of key enzymes (PAH) or cofactors (BH4) in the phenylalanine metabolic pathway, so that phenylalanine cannot be converted into tyrosine, resulting in phenylalanine and tyrosine. Its keto acid accumulates in the brain and plasma, also known as hyperphenylalaninemia (HPA), and the phenylalanine in the body is mainly excreted in the urine. The typical symptoms begin to appear when the patient is 3-4 months old, and the symptoms are obvious wh...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/00C12N15/70C12N15/75C12N15/81C12N15/80C12N15/90A23L33/17A61K38/16A61P19/06C12R1/19C12R1/10C12R1/84C12R1/885
CPCC07K14/00A23V2002/00A61K38/00A61P3/00A23L33/195A23V2250/546A23V2200/30
Inventor 刘海峰刘艳红宋保平李春艳
Owner 湖北康肽药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products